Aspen Wedge Breakout looks promising to R194.76Falling Wedge has formed on Aspen.
The price has broken out and looks like it's set to rally.
A conservative trader could wait for a retest, or an impulse trader could trigger it now.
7>21>200 -Bullish
RSI >50
Target - R194.76
SMC: Sell Side LIquidity
Smart Money buys into positions (and sweeps liquidity) from traders who are long (get stopped) and for short traders who enter into their trades.
ABOUT THE COMPANY
Aspen Pharmacare is a leading global pharmaceutical company with a deep footprint in both emerging and developed markets.
Founded in South Africa:
Aspen Pharmacare was founded in 1850 in South Africa, starting as a single pharmacy in Durban.
Global Presence:
Aspen has a strong international presence, with operations in about 56 countries across six continents.
Product Range:
The company’s primary business is in the provision of branded and generic pharmaceutical products, as well as infant nutritionals and consumer healthcare products.
Leadership:
The company was co-founded by South African businessman Stephen Saad, who remains the CEO.
Significant Player in ARVs:
Aspen is one of the world's largest suppliers of antiretroviral (ARV) drugs for treating HIV/AIDS, contributing to the global fight against the disease.
Manufacturing Prowess:
Aspen owns and operates 23 manufacturing facilities across 15 sites, demonstrating its vast manufacturing capabilities.
Jseapn
$JSE-APNJSE:APN
Publishing results after close today. There are small head and shoulders in place with moving averages getting red.
On the other hand it is holding very well today with all selling on our markets.
What is interesting all market action is contained in daily bar on 19 March 2019 and very bad results published.
Are ASPEN's Woes Nearly Over?Aspen is a global supplier and manufacturer of branded and generic pharmaceutical products as well as infant nutritionals and consumer healthcare products in selected territories.
ASPEN has been under the microscope over the past few years with various negative rumors and investigations driving the share price lower and lower. I believe that we haven't quite seen the bottom yet but that there is a possibility of strength to come soon. Perhaps a take over is what they need?
Technicals
The corrective structure has seen a break of the 61.8% Fib retracement level and is currently trading below it. I am expecting to see wave 3 end at the 78.6% level. In my opinion, it is likely that there will be a rally from that point onwards and that the structure will break to the upside. A larger retracement than that would indicate serious repercussions for ASPEN and I am certain that they will do everything in their power to avert a further decline in share price.